Duan Yongping made another move in the first quarter: increase Alibaba holdings and rebuild positions in Pinduoduo

① The first quarter of 2024 held 9 stocks, the same number as in the fourth quarter of 2023. Of these, 8 stocks continued to be held, 1 additional stock was added to Pinduoduo, and at the same time, it was a happy time to clear the inventory. ② According to Qu Fang, an investment advisor at Wanlian Securities, Duan Yongping is optimistic about Alibaba partly because its current valuation is undervalued.

cls.cn21minutes ago

Damo reveals new materials for Nvidia's AI chips: supply chain launched, two segments have new changes

Damo brought in some new materials in the GB200 supply chain, and Xiaomo continues to be optimistic about storage price increases.

wallstreetcn06:15

Top Institutions' Q1 US Stock Positions Revealed! Technology stocks have once again become the first choice for “smart money”. Where are the market trends pointing?

Berkshire drastically reduced its Apple holdings by 116 million shares in the first quarter, and its share of holdings fell to 41%; the biggest increase in Tiger Global Fund's holdings was Google, which increased its holdings by 154.1%; among Qiaoshui's holdings, Pinduoduo and NIO reduced their holdings by 36.61% and 48.05%.

Futu News05:57

Wall Street Eyes Breather After Record Run As Walmart Earnings, Fed Speakers In Focus: Analyst Banks Hopes On Nvidia Print, H2 Rate-Cut

Stocks may take a breather after Wednesday's record run, fueled by a mild consumer price inflation report, with index futures holding relatively steady in early trading. However, traders might find so

Benzinga05:53

Eli Lilly's QWINT-2 And QWINT-4 Phase 3 Trials Of Once-weekly Insulin Efsitora In Type 2 Diabetes Patients Using Insulin For First Time And Require Multiple Daily Injections, Efsitora Showed Non-Inferior A1C Reduction Vs. Most Commonly Used Daily Insulin

Efsitora met the primary endpoint in both QWINT-2 and QWINT-4 with once-a-week dosing regimen for people living with type 2 diabetesEfsitora was equally safe and effective among adults naïve to insul

Benzinga05:49

Roche Obesity Therapy Leads to ~19% Weight Loss in Phase 1 Trial

Seeking Alpha05:48